The FDA Just Approved a Longer-Lasting Lip Filler
Credit: GETTY IMAGES/ IMAGE USED FOR ILLUSTRATIVE PURPOSES ONLY
What makes this new-on-the-block option different from the rest of Restylane’s hyaluronic acid fillers? According to New York dermatologist Joshua Zeichner, MD, it’s the unique cross-linking technology that gives the substance a balance between structure and flexibility. “Its structure offers the versatility of use across different patient needs, allowing us to treat both structure and fullness of the lips with one product.”
“Restylane Kysse was specifically designed for the lips and has particles that are smaller than some of the other products,” adds West Palm Beach, FL dermatologist Kenneth Beer, MD, whose South-Florida practice was a clinical trial site for the new filler.
While Kysse is not yet commercially available, Dr. Zeichner notes that, according to clinical studies, the filler’s effects were shown to last up to one year—a welcome jump from the typical six-to-nine-month period many HA fillers tend to stick around for. “This will be especially helpful for patients who have a low pain tolerance for injections or those who are unable to get to the office as frequently as they would like,” adds Dr. Zeichner.
According to the FDA, who is holding off on any promotion of the approval for now, the filler was approved “for injection into the lips for lip augmentation and for correction of upper perioral rhytids in patients over the age of 21.”
However, unwelcome timing doesn’t go unnoticed. “The approval during a pandemic is less than optimal,” notes Dr. Beer. “However, I still have patients making appointments for when life resumes.” Dr. Zeichner adds: “All of our health efforts are focusing on controlling the COVID-19 pandemic right now. My hope is that one day soon, we will be in a place where we can begin to think of elective procedures again.”